Christoph Westphal - Director, Flex Pharma, Inc

As of July 27, 2017


Christoph Westphal Net Worth

  • Net worth is estimated to be at least $122.78M
  • Owns at least 7,153,979 units of Flex Pharma, Inc stock

Christoph Westphal Trading

  • Largest purchase of shares was 89,680 units , worth over $627.76K on March 15, 2016
  • In total has made about 63 transactions over 2 years
  • Usually trades in June, with the busiest year in 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christoph Westphal Mailing Address

  • Mailing address is C/o Alnylam Pharmaceuticals, Inc 300 Third Street Cambridge MA 02142 MA

Flex Pharma, Inc Insider Trading

  • The most recent transaction was 337,000 units sold on January 10, 2019 by Boston Foundation Inc worth over $123.85K
  • In the last 4 years, insiders at Flex Pharma, Inc sold an estimated value of $6.11M and bought an estimated value of $6.85M
  • The most active traders are Christoph H Westphal,  Barton Peter Hutt, Director,  and John McCabe, Chief Financial Officer
  • Insider trading is most common in July, with the busiest year in 2015

Flex Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1